Exploring bacterial metabolites in microbe-human host dialogue and their therapeutic potential in Alzheimer's diseases

被引:0
|
作者
Singh, Sarangthem Dinamani [1 ,3 ]
Bharali, Pankaj [2 ,3 ]
Nagamani, Selvaraman [1 ,3 ]
机构
[1] CSIR North East Inst Sci & Technol CSIR NEIST, Adv Computat & Data Sci Div, Jorhat 785006, India
[2] CSIR North East Inst Sci & Technol CSIR NEIST, Ctr Infect Dis, Biol Sci & Technol Div, Jorhat 785006, Assam, India
[3] Acad Sci & Innovat Res AcSIR, Ghaziabad 201002, India
关键词
Alzheimer's disease; Microbiota signaling target metabolites network analysis; Gut microbiota; Molecular docking; GUT MICROBIOTA; TARGET; GSK3; PHARMACOLOGY; PLATFORM; DATABASE; GENES;
D O I
10.1007/s11030-024-11028-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurological dysfunction in association with aging, dementia, and cognitive impairment is the major cause of Alzheimer's disease (AD). Current AD therapies often yield unsatisfactory results due to their poor mechanism in treating the underlying mechanism of the disease. Recent studies suggested that metabolites from the gut microbiota facilitate brain-gut communication. A systematic network pharmacology study and the structure- and analog-based approaches are employed to investigate the metabolites produced by gut microbiota to treat AD. The microbiota metabolites available in the gutMGene database were considered in this study. Two servers, namely Swiss Target Prediction (STP) and Similarity Ensemble Approach (SEA), were used to identify the possible AD targets for the selected metabolites. Detailed KEGG pathway and Gene Ontology (GO) analysis on identified hub genes highlighted the importance of IL6, AKT1, and GSK3B in AD pathophysiology. MMTSp (Microbiota Metabolites Target Signaling pathways) network analysis elucidated that there is a strong relationship with microbiota (Paraprevotella xylaniphila YIT 11841, Bifidobacterium dentium, Paraprevotella clara YIT 11840, Enterococcus sp. 45, Bacteroides sp. 45, Bacillus sp. 46, Escherichia sp. 33, Enterococcus casseliflavus, Bacteroides uniformis, Alistipes indistinctus YIT 12060, Bacteroides ovatus, Escherichia sp. 12, and Odoribacter laneus YIT 12061) and AD pathogenesis. In addition to this, we performed molecular docking to study the metabolite interactions in the AD drug targets. The ADME/T properties of these metabolites were also calculated and the results are discussed in detail.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Exploring therapeutic potential of Bacopa monnieri bioactive compounds against Alzheimer's and Parkinson's diseases
    Shukla, Richa
    Mishra, Krishna
    Singh, Sangeeta
    3 BIOTECH, 2025, 15 (03)
  • [2] Exploring the Potential of Antidiabetic Agents as Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: A Comprehensive Review
    Koshatwar, Mahima
    Acharya, Sourya
    Prasad, Roshan
    Lohakare, Tejaswee
    Wanjari, Mayur
    Taksande, Avinash B.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [3] Exploring the Therapeutic Potential of Noncoding RNAs in Alzheimer's Disease
    Tripathi, Siddhant
    Sharma, Yashika
    Kumar, Dileep
    PROTEIN AND PEPTIDE LETTERS, 2024, 31 (11): : 862 - 883
  • [4] Gut microbiota metabolites: potential therapeutic targets for Alzheimer's disease?
    Zhang, Shanshan
    Lu, Jing
    Jin, Ziqi
    Xu, Hanying
    Zhang, Dongmei
    Chen, Jianan
    Wang, Jian
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [5] Ferroptosis as a Therapeutic Target in Neurodegenerative Diseases: Exploring the Mechanisms and Potential of Treating Alzheimer's Disease and Parkinson's Disease
    Zhong, Hui
    Liu, Hanxiang
    Fu, Qiang
    PROTEIN AND PEPTIDE LETTERS, 2024, 31 (10): : 759 - 772
  • [6] MicroRNAs and Their Therapeutic Potential for Human Diseases: Aberrant MicroRNA Expression in Alzheimer's Disease Brains
    Satoh, Jun-ichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 114 (03) : 269 - 275
  • [7] Exploring the therapeutic potential of steroidal alkaloids in managing Alzheimer's disease
    Pandey, Pratima P.
    Kumar, Maushmi S.
    STEROIDS, 2024, 209
  • [8] Neuroprotective Potential of Melatonin: Evaluating Therapeutic Efficacy in Alzheimer's and Parkinson's Diseases
    Talbot, Norris C.
    Luther, Patrick M.
    Spillers, Noah J.
    Ragland, Amanda R.
    Kidder, Evan J.
    Kelkar, Rucha A.
    Varrassi, Giustino
    Ahmadzadeh, Shahab
    Shekoohi, Sahar
    Kaye, Alan D.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [9] Exploring the therapeutic potential of cyclopeptides from Stachys geobombycis in Alzheimer's disease
    Marunganathan, Vanitha
    Guru, Ajay
    NATURAL PRODUCT RESEARCH, 2024,
  • [10] Exploring the Therapeutic Potential of Glycyrrhiza Compounds in Alzheimer's Disease: A Comprehensive Review
    Song, Xiaona
    Wang, Xiaotang
    Gao, Yao
    Xu, Guoqiang
    Yan, Xiaoru
    Chen, Zhaoyang
    Song, Guohua
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2025, 25 (03) : 286 - 310